1. Pouya MJ, Yaghoubi S, Darabi F, Mousavi Z, Falahi J. Environmental Surface Circulation of SARS-CoV-2 RNA in Asadabad Hospital Wards. Clinical Laboratory. 2022 Feb 1;68(2). [
DOI] [
PMID]
2. Suwantika AA, Zakiyah N, Diantini A, Abdulah R, Postma MJ. The role of administrative and secondary data in estimating the costs and effects of school and workplace closures due to the covid-19 pandemic. Data. 2020;5(4):98. [
DOI]
3. Moradi A, Mirzaei M, Ameri P, Zangeneh M, Moradi A, Darabi F. Spatial Analysis of Covid-19 Disease in Hamadan Province. Payesh 2024; 23 (2) :271-287. https://doi.org/ 10.61186/payesh.23.2.271 [
DOI]
4. Candelli M, Pignataro G, Torelli E, Gullì A, Nista EC, Petrucci M, et al. Effect of influenza vaccine on COVID-19 mortality: A retrospective study. Internal and Emergency Medicine. 2021;16(7):1849-55. [
DOI] [
PMID] [
PMCID]
5. Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19 infection. The Lancet Infectious Diseases. 2020;20(7):773. [
DOI] [
PMID]
6. Coronavirus disease. New cases and deaths. Available at: https://www.worldometers.info/coronavirus/country/iran/. [
URL]
7. Takian A, Raoofi A, Kazempour-Ardebili S. COVID-19 battle during the toughest sanctions against Iran. The Lancet. 2020;395(10229):1035. [
DOI] [
PMID]
8. Kumari A, Ranjan P, Chopra S, Kaur D, Kaur T, Upadhyay AD, et al. Knowledge, barriers and facilitators regarding COVID-19 vaccine and vaccination programme among the general population: a cross-sectional survey from one thousand two hundred and forty-nine participants. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2021;15(3):987-92. [
DOI] [
PMID] [
PMCID]
9. Centers for Disease Control and Prevention. Science Brief: COVID-19 Vaccines and Vaccination. Available at: https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/index.html. [
URL]
10. Díaz J, Antonio-López-Bueno J, Culqui D, Asensio C, Sánchez-Martínez G, Linares C. Does exposure to noise pollution influence the incidence and severity of COVID-19? Environmental Research. 2021;195:110766. [
DOI] [
PMID] [
PMCID]
11. Noor FM, Islam M. Prevalence and associated risk factors of mortality among COVID-19 patients: a meta-analysis. Journal of Community Health. 2020;45(6):1270-82. [
DOI] [
PMID] [
PMCID]
12. Gupta S, Cantor J, Simon KI, Bento AI, Wing C, Whaley CM. Vaccinations Against COVID-19 May Have Averted Up To 140,000 Deaths In The United States: Study examines role of COVID-19 vaccines and deaths averted in the United States. Health Affairs. 2021. [
DOI] [
PMID] [
PMCID]
13. Taghinezhad-S S, Mohseni AH, Bermúdez-Humarán LG, Casolaro V, Cortes-Perez NG, Keyvani H, et al. Probiotic-based vaccines may provide effective protection against COVID-19 acute respiratory disease. Vaccines. 2021;9(5):466. [
DOI] [
PMID] [
PMCID]
14. World Health Organization. Coronavirus disease (COVID-19): Vaccines. Available at: https://www.who.int/news-room/q-and-a/detail/covid-19-vaccines. [
URL]
15. Roghani A. The influence of Covid-19 vaccine on daily cases, hospitalization, and death rate in Tennessee: a case study in the United States. medRxiv. 2021. [
DOI]
16. Li H, Wang S, Zhong F, Bao W, Li Y, Liu L, et al. Age-dependent risks of incidence and mortality of COVID-19 in Hubei Province and other parts of China. Frontiers in Medicine. 2020;7:190. [
DOI] [
PMID] [
PMCID]
17. Yang M-J, Rooks BJ, Le T-TT, Santiago IO, Diamond J, Dorsey NL, et al. Influenza vaccination and hospitalizations among COVID-19 infected adults. Journal of the American Board of Family Medicine. 2021;34(Supplement):S179-S82. [
DOI] [
PMID]
18. Algaissi AA, Alharbi NK, Hassanain M, Hashem AM. Preparedness and response to COVID-19 in Saudi Arabia: Building on MERS experience. Journal of Infection and Public Health. 2020;13:834-8. [
DOI] [
PMID] [
PMCID]
19. Dal-Ré R, Caplan AL, Gluud C, Porcher R. Ethical and scientific considerations regarding the early approval and deployment of a COVID-19 vaccine. Annals of Internal Medicine. 2021;174:258-60. [
DOI] [
PMID] [
PMCID]
20. Alhazmi A, Alamer E, Daws D, Hakami M, Darraj M, Abdelwahab S, et al. Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia. Vaccines. 2021;9:674. [
DOI] [
PMID] [
PMCID]
21. Moghadas SM, Vilches TN, Zhang K, Wells CR, Shoukat A, Singer BH, et al. The impact of vaccination on coronavirus disease 2019 (COVID-19) outbreaks in the United States. Clinical Infectious Diseases. 2021;73(12):2257-64. [
DOI] [
PMID] [
PMCID]
22. Ghiasi N, Valizadeh R, Arabsorkhi M, Hoseyni TS, Esfandiari K, Sadighpour T, et al. Efficacy and side effects of Sputnik V, Sinopharm and AstraZeneca vaccines to stop COVID-19; a review and discussion. Immunopathologia Persa. 2021;7(2):e31-e. [
DOI]
23. Beatty AL, Peyser ND, Butcher XE, Cocohoba JM, Lin F, Olgin JE, et al. Analysis of COVID-19 vaccine type and adverse effects following vaccination. JAMA Network Open. 2021;4(12):e2140364. [
DOI] [
PMID] [
PMCID]
24. Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. New England Journal of Medicine. 2020;383:2603-15. [
DOI] [
PMID] [
PMCID]
25. Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. The Lancet. 2021;397:99-111. [
DOI] [
PMID]
26. Taherian Z, Rezaei M, Haddadpour A, Amini Z. The Effect of COVID-19 Vaccination on Reducing the Risk of Infection, Hospitalization, and Death in Isfahan Province, Iran. Iranian Journal of Public Health. 2022;51(1):188. [
DOI]
27. Wise J. Covid-19: New data on Oxford AstraZeneca vaccine backs 12 week dosing interval. British Medical Journal. 2021. [
DOI] [
PMID]
28. Bernal JL, Andrews N, Gower C, Stowe J, Robertson C, Tessier E, et al. Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England. MedRxiv. 2021. [
DOI]
29. Brosh-Nissimov T, Orenbuch-Harroch E, Chowers M, Elbaz M, Nesher L, Stein M, et al. BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel. Clinical Microbiology and Infection. 2021;27(11):1652-7. [
DOI] [
PMID] [
PMCID]
30. Wong LP, Wong PF, AbuBakar S. Vaccine hesitancy and the resurgence of vaccine preventable diseases: the way forward for Malaysia, a Southeast Asian country. Human Vaccines & Immunotherapeutics. 2020;16(7):1511-20. [
DOI] [
PMID] [
PMCID]